The effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double-blind study.

Suppr

超能文献

作者信息

Hamazaki T, Hirayama S

出版信息

Eur J Clin Nutr. 2004 May;58(5):838. doi: 10.1038/sj.ejcn.1601888.

DOI:10.1038/sj.ejcn.1601888

PMID:15116088

Abstract

摘要

相似文献

The effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double-blind study.

Eur J Clin Nutr. 2004 May;58(5):838. doi: 10.1038/sj.ejcn.1601888.

Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study.

Eur J Clin Nutr. 2004 Mar;58(3):467-73. doi: 10.1038/sj.ejcn.1601830.

Effects of sugar on aggressive and inattentive behavior in children with attention deficit disorder with hyperactivity and normal children.

Pediatrics. 1991 Nov;88(5):960-6.

The effect of fish oil on physical aggression in schoolchildren--a randomized, double-blind, placebo-controlled trial.

J Nutr Biochem. 2005 Mar;16(3):163-71. doi: 10.1016/j.jnutbio.2004.10.009.

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.

Pediatrics. 2005 Dec;116(6):e777-84. doi: 10.1542/peds.2005-0617.

Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?

J Dev Behav Pediatr. 2009 Apr;30(2):158-68. doi: 10.1097/DBP.0b013e31819f1c15.

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Pediatrics. 2008 Jan;121(1):e73-84. doi: 10.1542/peds.2006-3695.

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

Child Care Health Dev. 2006 Sep;32(5):575-83. doi: 10.1111/j.1365-2214.2006.00631.x.

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.

Pediatrics. 2008 Feb;121(2):e314-20. doi: 10.1542/peds.2006-1880.

Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.

Altern Med Rev. 2007 Sep;12(3):207-27.

引用本文的文献

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.

Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment.

Neuropsychiatr Dis Treat. 2016 Jul 26;12:1869-82. doi: 10.2147/NDT.S68652. eCollection 2016.

Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.

J Child Adolesc Psychopharmacol. 2015 Dec;25(10):775-82. doi: 10.1089/cap.2015.0052.

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2.

Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.

Nutr J. 2007 Jul 13;6:16. doi: 10.1186/1475-2891-6-16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验